YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity

YIV-906 is a systems biology botanical cancer drug, inspired by a traditional Chinese herbal formulation. Results from eight Phase I/II to II clinical studies demonstrated the potential of YIV-906 to prolong survival and improve the quality of life of cancer patients. As an immunomodulator in the tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Wing, Hu, Rong, Liu, Shwu-Huey, Cheng, Peikwen, Cheng, Yung-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846171/
https://www.ncbi.nlm.nih.gov/pubmed/36686648
http://dx.doi.org/10.3389/fphar.2022.1095186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846171/
https://www.ncbi.nlm.nih.gov/pubmed/36686648
http://dx.doi.org/10.3389/fphar.2022.1095186

Ejemplares similares